Daily Archives: March 5, 2020

Moore Nanotechnology ประกาศเปิดตัว Shanghai Tech Center

SWANZEY, N.H., March 05, 2020 (GLOBE NEWSWIRE) — Moore Nanotechnology Systems (“Nanotech”) ซัพพลายเออร์ชั้นนำของโลกด้านระบบเครื่องจักรที่มีความแม่นยำสูง และ DKSH กลุ่มบริการขยายตลาดชั้นนำในจีนแผ่นดินใหญ่ ได้ประกาศเปิดตัวการสาธิต การฝึกอบรม และศูนย์การใช้งานของ Ultra-Precision Machining (UPM) และศูนย์การใช้งานใน Minhang District ของเซี่ยงไฮ้

ส่วนอำนวยความสะดวก 350 ตารางเมตรจะช่วยให้ลูกค้าของ Nanotech สามารถเข้าถึงได้ทั้งในชั้นเรียนและการสาธิตแบบลงมือของเครื่องกลึงเพชรขนาดกะทัดรัด 250UPLV2 ซึ่งใช้สำหรับการผลิตเลนส์ออพติคัลแบบ Spherical & Aspherical, เข็มหมุด, กระจก, เลนส์อิสระ และส่วนประกอบที่ต้องใช้งานเครื่องจักรกลที่แม่นยำอื่นๆ  นอกเหนือจากการกลึงเพชรแบบจุดเดียว ศูนย์ยังจะเสนอการเข้าถึงอุปกรณ์มาตรวิทยาที่เกี่ยวข้อง การประยุกต์ใช้งานด้านวิศวกรรม และการสนับสนุนซอฟต์แวร์ NanoCAM®4 ผ่านรูปแบบการฝึกอบรม การประชุม และการพูดคุยแบบ 1:1

Scott Gerhart รองประธานฝ่ายขายและการตลาดสำหรับ Nanotech กล่าวว่า “Nanotech ยังคงมีการเติบโตอย่างต่อเนื่องตลอดทั่วทั้งเอเชีย เพื่อรวมเอาแอปพลิเคชันเฉพาะสำหรับโมดูลกล้อง ผลิตภัณฑ์อิเล็กทรอนิกส์ผู้บริโภค และภาคส่วนยานยนต์ ซึ่งเป็นเวลาที่เหมาะสมในการเข้าร่วมกับ DKSH พันธมิตรในภูมิภาคของเราและแสดงให้เห็นถึงความมุ่งมั่นของเราต่อลูกค้าผ่านศูนย์ที่ทันสมัยแห่งนี้”  Mr. Gerhart กล่าวต่อว่า “ส่วนอำนวยความสะดวกจะดีเช่นนี้ได้ก็ด้วยบุคลากรที่ดีในการสนับสนุน ซึ่งนี่คือเหตุผลว่าทำไมเราถึงตื่นเต้นที่จะต้อนรับ Dr. David Robinson เข้าสู่ทีมของ Nanotech  การดำรงตำแหน่งยาวนานของ Dr. Robinson ในฐานะรองผู้อำนวยการฝ่ายออพติกที่แม่นยำที่มหาวิทยาลัย Durham ในสหราชอาณาจักร ประกอบกับชื่อเสียงของเขาในฐานะผู้บุกเบิกการกลึงเพชร ทำให้เขาเป็นตัวเลือกที่สมบูรณ์แบบในการนำกิจกรรมแอปพลิเคชันเหล่านี้ โดยทำงานร่วมกันกับ DKSH”

Oliver Hammel กรรมการผู้จัดการ DKSH Technology Systems ประเทศจีน กล่าวเสริมว่า “การลงทุนที่เราทำในส่วนอำนวยความสะดวกระดับโลกแห่งนี้แสดงให้เห็นว่าเรามุ่งมั่นที่จะสร้างแบรนด์ให้กับพันธมิตรสำคัญของเราในประเทศจีนได้อย่างไร DKSH จะสามารถให้บริการด้านโซลูชันวิศวกรรมที่ดีที่สุดในระดับเดียวกัน พร้อมด้วยการทดสอบการตัดเปลี่ยนรูปเพชร ที่ไซต์ในประเทศจีน  ไม่มีอะไรที่น่ายินดีไปกว่านี้สำหรับเราในการเพิ่มความร่วมมือกับ Nanotech ในด้านพื้นที่ออพติกผู้บริโภคและยานยนต์แบบไดนามิกที่มีการเติบโตสูง”

Mark Boomgarden ประธานและ CEO ของ Nanotech ได้แสดงความเห็นว่า “Nanotech พบว่ามีการเติบโตอย่างมากทั่วโลกตามความต้องการของระบบออพติคัลที่มีประสิทธิภาพสูงยังคงเพิ่มขึ้นอย่างต่อเนื่อง การมีแอปพลิเคชันระดับโลกและความเชี่ยวชาญด้านการฝึกอบรมใกล้กับศูนย์ออกแบบและการผลิตของลูกค้าในเอเชียของเราจะช่วยให้เราสามารถสาธิตอุปกรณ์ชั้นนำของตลาดและซอฟต์แวร์ NanoCAM4 แบบเรียลไทม์ได้ดียิ่งขึ้น DKSH มีวิสัยทัศน์ร่วมกับเราในการเป็นลูกค้าชื่อแรกที่ต้องพิจารณาเมื่อซื้ออุปกรณ์เครื่องจักรที่มีความแม่นยำสูง และนี่เป็นเพียงอีกก้าวหนึ่งของ Nanotech ที่จะแบ่งปันความมุ่งมั่นของเราต่ออุตสาหกรรม”

Moore Nanotechnology Systems (Nanotech) ก่อตั้งขึ้นใน Keene, NH ในปี 1997 เป็นบริษัทในเครือของ Moore Tool Company Nanotech คือผู้นำระดับโลกด้านการออกแบบ พัฒนา และผลิตเครื่องมือเครื่องจักรที่มีความแม่นยำสูงและกระบวนการที่เกี่ยวข้อง (การกลึงเพชรแบบจุดเดียว การกัดระดับไมโคร การขัดระดับไมโคร และการหล่อแบบด้วยแผ่นกระจก) สำหรับการผลิตส่วนประกอบออพติคัลขั้นสูงในภาคส่วนอุปกรณ์อิเล็กทรอนิกส์สำหรับผู้บริโภค การทหาร การบินและอวกาศ การให้แสงสว่าง การแพทย์ และยานยนต์ Moore Tool ก่อตั้งขึ้นในปี 1924 และตั้งอยู่ที่ Bridgeport, Connecticut มีประวัติอันยาวนานในตลาดเครื่องมือเครื่องจักรที่มีความแม่นยำสูง ในปัจจุบัน Moore Tool ให้บริการสายการผลิต CNC Jig Grinder ประสิทธิภาพสูง พร้อมบริการการผลิตที่มีความแม่นยำซึ่งได้รับการรับรองทั้ง ISO 9001:2008 และ AS9100C Moore Nanotechnology และ Moore Tool นั้นถูกรวมเข้าด้วยกันภายใต้กลุ่ม PMT

Moore Nanotechnology Systems: www.nanotechsys.com
Moore Tool, Inc: www.mooretool.com

DKSH เป็นผู้ให้บริการการขยายตลาดชั้นนำโดยมุ่งเน้นที่เอเชีย กลุ่มบริษัทช่วยให้บริษัทต่างๆ เติบโตในหน่วยธุรกิจผลิตภัณฑ์เพื่อสุขภาพ สินค้าอุปโภคบริโภค วัสดุด้านประสิทธิภาพและเทคโนโลยี ผลงานด้านการบริการครอบคลุมการจัดหา ข้อมูลเชิงลึกทางการตลาด การตลาดและการขาย eCommerce การจัดจำหน่ายและการขนส่ง รวมถึงบริการหลังการขาย บริษัทได้จดทะเบียนในตลาดหลักทรัพย์ SIX Swiss Exchange กลุ่มบริษัทดำเนินงานใน 36 ตลาดพร้อมผู้เชี่ยวชาญ 33,350 คน สร้างยอดขายสุทธิ 11.6 พันล้านฟรังก์สวิสในปี 2019 ด้วยผลตกทอดจากสวิส DKSH จึงได้ฝังรากลึกในเอเชียแปซิฟิกตั้งแต่ปี 1865 เทคโนโลยีหน่วยธุรกิจ DKSH นำเสนอโซลูชันที่สมบูรณ์แบบสำหรับการใช้งานในอุตสาหกรรมเฉพาะทาง ด้วยผู้เชี่ยวชาญกว่า 1,670 คน หน่วยธุรกิจสร้างยอดขายสุทธิ 431.9 ล้านฟรังก์สวิสในปี 2019

สำหรับรายละเอียดเพิ่มเติม โปรดติดต่อ

Moore Nanotech Systems, LLC
Scott Gerhart
รองประธาน, ฝ่ายขายและการตลาด
โทร. +1 603 352 3030
gerhart@nanotechsys.com

DKSH  Ltd.
Irene Chen
ผู้อำนวยการ, การตลาดกลุ่ม, เทคโนโลยี
โทร.  +886 2 8752 6666 Ext. 611
irene.yr.chen@dksh.com

Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing

EDMONTON, Alberta, March 04, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce that Health Canada has approved the Company’s application to amend its existing Standard Processors License to include its Edmonton II facility for the processing of cannabis materials.

Radient’s Edmonton II Facility (“Edmonton II”), which the Company has retrofitted to accommodate the extraction and downstream processing of CBD from hemp, was designed to process both cannabis and hemp materials to produce high quality cannabinoid extracts. Edmonton II also gives the Company manufacturing capacity to accelerate the development of white label ‘Cannabis 2.0’ products. A portion of the facility will be used to manufacture high quality cannabis end products for Radient’s clients, representing another important milestone in expanding the Company’s product offerings. Following a commissioning phase, the Edmonton II facility is expected to begin commercial operations in the second half of calendar 2020.

Closing of First Tranche of Debenture Financing:

Radient also announces today that further to its announcement dated February 10, 2020, the Company has closed the initial tranche (the “Initial Tranche”) of its previously announced debenture financing of up to CAD$5 million of unsecured debentures (the “Debentures”).

Pursuant to the Initial Tranche, Radient has issued Debentures for a principal amount of CAD$1,162,500. The Debentures are unsecured and have an interest rate of 15% per annum. The Debentures will mature on March 3, 2022 (the “Maturity Date”). The Company has issued to the Debenture holders 581,250 non-transferable common share purchase warrants (the “Bonus Warrants”). Each Bonus Warrant has a 24 month term and is exercisable into one common share of the Company at an exercise price of CAD $0.70 per share (each a “Bonus Share”). All Bonus Shares will be subject to a hold period expiring on July 4, 2020 in accordance with applicable securities laws.

The Company plans to use the proceeds from Initial Tranche for general working capital purposes.

An aggregate of $125,000 of the Debentures were purchased by Denis Taschuk, the President and CEO of the Company and an aggregate of $400,000 of the Debentures were purchased by Mr. Yves Gougoux, a Director of the Company. The issuance of the Debentures and the Bonus Warrants to Mr. Taschuk and Mr. Gougoux constitutes a “related party transaction” under Multilateral Instrument 61-101 – Protection of Minority Holders in Special Transactions (“MI 61-101”). The Company is relying, however, on an exemption from the valuation and minority voting requirements of MI 61-101.

About Radient

Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary continuous-flow extraction and processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.

SOURCE: Radient Technologies Inc.

Investors please contact: Adam Deffett, Senior VP of Corporate Development: adeffett@radientinc.com

Media/press please contact: Caitlin Cheadle, Director of Communications: ccheadle@radientinc.com

Forward-Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the Initial Tranche; the Company’s ability to close on subsequent tranches;; the Company’s ability to expand its business internationally; the Company’s ability, and timing, to commission Edmonton II; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2020 Financial Results; Host Conference Call April 3, 2020

VICTOR, N.Y., March 04, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today it will report financial results for its full fiscal year and fourth quarter ended February 29, 2020, on Friday, April 3, 2020, before the open of the U.S. markets. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer Bill Newlands and Executive Vice President and Chief Financial Officer Garth Hankinson at 10:30 a.m. EDT, April 3, 2020.

The conference call can be accessed by dialing +1-877-673-1771 and entering conference identification number 3770886, beginning at 10:20 a.m. EDT. A live, listen-only webcast of the conference call will be available on the company’s website, www.cbrands.com, under the Investors/Events & Presentations section. When the call begins, financial information discussed on the conference call, and a reconciliation of reported (GAAP) financial measures with comparable or non-GAAP financial measures, will also be available on the company’s website under Investors and by selecting Reporting. For anyone unable to participate in the conference call, a replay will be available on the company’s website.

ABOUT CONSTELLATION BRANDS
At Constellation Brands (NYSE: STZ and STZ.B), our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching For. It’s worth our dedication, hard work, and the bold calculated risks we take to deliver more for our consumers, trade partners, shareholders, and communities in which we live and work. It’s what has made us one of the fastest-growing large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what’s next.

Today, we are a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Every day, people reach for our high-end, iconic imported beer brands such as Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra, and Pacifico, and our high-quality premium wine and spirits brands, including the Robert Mondavi brand family, Kim Crawford, Meiomi, The Prisoner brand family, SVEDKA Vodka, Casa Noble Tequila, and High West Whiskey.

But we won’t stop here. Our visionary leadership team and passionate employees from barrel room to boardroom are reaching for the next level, to explore the boundaries of the beverage alcohol industry and beyond. Join us in discovering what’s Worth Reaching For.

To learn more, follow us on Twitter @cbrands and visit www.cbrands.com.

A downloadable PDF copy of this news release enhanced with multimedia links can be found here: http://ml.globenewswire.com/Resource/Download/816c2eaa-e080-472c-91bc-2d6058789907

MEDIA CONTACTS INVESTOR RELATIONS CONTACTS
Mike McGrew 773-251-4934 / michael.mcgrew@cbrands.com
Amy Martin 585-678-7141 / amy.martin@cbrands.com
Patty Yahn-Urlaub 585-678-7483 / patty.yahn-urlaub@cbrands.com
Bob Czudak 585-678-7170 / bob.czudak@cbrands.com

Align Technology to Acquire Global Dental CAD/CAM Software Leader Exocad

  • exocad’s restorative expertise and dental CAD/CAM solutions broaden and strengthen Align’s digital dentistry platform for doctors, labs, and partners worldwide
  • Expands the orthodontic market opportunity for doctors by integrating clear aligner orthodontics and restorative treatment with flexible, reliable, and easy-to-use CAD/CAM software and digital workflows

SAN JOSE, Calif. and DARMSTADT, Germany, March 04, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced that it has signed a definitive agreement to acquire privately held exocad Global Holdings GmbH (exocad) for approximately EUR376 million in cash. exocad is a global leader in the dental CAD/CAM software market and offers fully integrated workflows to dental labs and dental practices via a broad customer base of partners, and resellers in over 150 countries.

The acquisition of exocad strengthens the Align digital platform that delivers innovative tools and features for diagnostic, restorative, implant, and orthodontic workflows. The acquisition brings exocad’s expertise in restorative dentistry, implantology, guided surgery, and smile design to the Align technology portfolio, extending Align’s Invisalign and iTero digital solutions and paving the way for new, seamless cross-discipline dentistry in lab and at chairside. exocad also broadens Align’s platform reach in digital dentistry with close to 200 partners and more than 35,000 licenses installed worldwide.

“Dentistry today is evolving digitally, with technology advances and consumer awareness driving new opportunities in ortho-restorative and comprehensive treatment. Align is in a unique position to lead the digital transformation of dentistry by reimagining comprehensive treatment planning and by reinventing the way orthodontists and GPs practice with our digital platform for transforming smiles,” said Joe Hogan, Align Technology president and CEO. “exocad allows us to broaden and deepen Align’s digital platform by addressing restorative needs in our end-to-end digital platform that facilitate ortho-restorative and comprehensive dentistry and accelerates adoption of Invisalign treatment among the more than 300 million potential patients worldwide.”

This acquisition is a natural next step in the collaboration between Align and exocad that started in 2017 with the seamless integration of Align’s iTero intraoral scanners and exocad Chairside CAD software.  The collaboration later expanded to a fully-validated workflow that enabled in-house milling of dental restoration on any compatible milling machine, and most recently, at the Chicago Midwinter Meeting 2020, we announced the unique exocad Connector.

“I am excited by the enormous growth opportunity for exocad and its customers that comes with being a part of Align Technology,” said Tillmann Steinbrecher, CEO and co-founder of exocad. “Together, we will further strengthen exocad’s position as a key technology provider for the dental CAD/CAM industry and drive continuous innovation with the open and integrated approach that is the foundation of our company.”

exocad will continue to operate as it exists today, enabling it to support a broad ecosystem of partners and end-users and continue to deliver hardware-independent software solutions. exocad co-founders Tillmann Steinbrecher and Maik Gerth, along with their team, are expected to remain after the transaction closes and report into John Morici, Align Technology, senior vice president and CFO.

“The acquisition of exocad adds a talented and passionate team as well as a highly innovative, industry-leading product suite to our portfolio, providing an excellent complement to our current workflow solutions,” said Morici. “We will continue to invest in and build on exocad’s leadership in the dental CAD/CAM market and look to them to make significant contributions to Align’s overall strategy.”

Under the terms of the agreement, Align will pay approximately EUR376 million in cash to acquire exocad, which is majority owned by Carlyle Europe Technology Partners (CETP.) The acquisition is expected to close during the second quarter of 2020. Goldman Sachs & Co. LLC is serving as exclusive financial advisor to Align. UBS Investment Bank is serving as exclusive financial advisor to exocad and funds managed or advised by CETP.

Align anticipates that the acquisition of exocad is expected to be gross margin accretive, reflecting the strength of exocad’s software business. We expect GAAP EPS to be dilutive for the fiscal year 2020, due to acquisition-related costs.

Align Web Cast and Conference Call
Align will host a conference call today, March 4, 2020 at 4:30 p.m. ET, 1:30 p.m. PT, to discuss the acquisition of exocad. The conference call will also be web cast live via the Internet.  To access the webcast, go to the “Events & Presentations” section under Company Information on Align’s Investor Relations web site at http://investor.aligntech.com.  To access the conference call, please dial 201-689-8261. An archived audio web cast will be available beginning approximately one hour after the call’s conclusion and will remain available for approximately one month. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with conference number 13699954 followed by #. For international callers, please dial 201-612-7415 and use the same conference number referenced above. The telephonic replay will be available through 5:30 p.m. ET on March 18, 2020.

About Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we use certain non-GAAP financial measures including, non-GAAP gross profit, gross margin, operating expenses, income from operations, operating margin, effective tax rate, net income and diluted EPS, which exclude certain items that may not be indicative of our fundamental operating performance including discrete cash and non-cash charges or gains that are included in the most directly comparable GAAP measure. Non-GAAP measures may exclude the effects of acquisition related costs such as amortization of acquired intangibles and certain other transaction-related costs, stock-based compensation, non-cash deferred tax assets and associated amortization related to intra-entity transfer of non-inventory assets, impairments and other (gains) charges, and litigation settlement gains, and, if applicable, any associated tax impacts.

We use non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Management believes these non-GAAP financial measures provide meaningful supplemental information regarding our recurring core operating performance. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are provided to and used by our institutional investors and the analyst community to help them analyze the performance of our business.

There are limitations to using non-GAAP financial measures, though, because they are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact upon our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which charges are excluded from the non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a GAAP as well as a non-GAAP basis and also by providing GAAP measures in our public disclosures. The presentation of non-GAAP financial information is meant to be considered in addition to, not as a substitute for or in isolation from, the directly comparable financial measures prepared in accordance with GAAP. We urge investors to review the reconciliation of our GAAP financial measures to the comparable Non-GAAP financial measures as presented, and not to rely on any single financial measure to evaluate our business. For more information on these non-GAAP financial measures, please see http://investor.aligntech.com/index.php/static-files/3303d8d7-163b-42f1-8856-9468f474428a.

About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align’s products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com.

About exocad GmbH
exocad GmbH is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit www.exocad.com.

Forward-Looking Statements
This news release, including the tables below and other information publicly disseminated by us, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including quotations from management, statements regarding (i) expected transaction benefits and synergies as a result of the acquisition, (ii)  anticipated dilution and accretion, respectively, from the transaction, and (iii) expectations regarding the purchase price and timing of the transaction,  in addition to other matters discussed in this press release that are not purely historical data. We do not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise.  Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Among the factors that could cause actual results to differ materially from those contemplated include, without limitation:

  • the ability to: (i) realize expected synergies or benefits in connection with the proposed transaction within the expected timeframes or not at all and (ii) timely, cost-efficiently and effectively integrate exocad’s business without adversely impacting operations of either Align or exocad;
  • the effect of the announcement or closing of the proposed transaction on (i) Align’s and exocad’s relationships with their respective customers, suppliers, strategic partners and competitors and their operating results and businesses generally (including the diversion of management time on transaction-related issues) and (ii) the ability to retain and hire key personnel;
  • uncertainties associated with any aspect of the proposed transaction, including those related to (i) fluctuations in foreign exchange rates and transaction costs, and (ii) litigation in connection with the transaction itself or ongoing matters acquired from exocad;
  • the potential that our due diligence did not uncover risks and potential liabilities associated with the exocad;
  • risks relating to financial reporting including those resulting from the implementation of new or changed accounting policies and practices as well as associated system implementation in the context of the transaction as well as our ability to forecast financial results;
  • the potential impact of the transaction on our future tax rate and payments based on the consolidation of the global group and our ability to integrate foreign operations;
  • the potential negative effects of the announcement of the proposed transaction on the market price of the Company’s common stock;
  • difficulties predicting customer and consumer purchasing behavior;
  • expectations regarding the continued growth of our international markets;
  • increasing competition from existing and new competitors;
  • rapidly evolving and groundbreaking advances that are fundamentally changing the dental industry and the way new and existing participants market and provide products and services to consumers;
  • our ability to protect our intellectual property rights;
  • our expectations regarding sales growth of our intra-oral scanner sales in international markets and our belief that technology features and functionality of the iTero scanners will increase adoption of Invisalign and increase sales of our intra-oral scanners;
  • the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs or errors requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected, or that the expected benefits of new or existing business relationships will not be achieved as anticipated;
  • the compromise of employee, customer and/or patient data for any reason;
  • changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence; and
  • foreign operational, political and other risks relating to our international manufacturing operations.

The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the Securities and Exchange Commission (SEC) on February 28, 2020. Securities and Exchange Commission filings can be accessed over the Internet at http://www.sec.gov/edgar/searchedgar/companysearch.html. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Align Technology
Madelyn Homick
(408) 470-1180
mhomick@aligntech.com
Zeno Group
Sarah Johnson
(828) 551-4201
sarah.johnson@zenogroup.com